Detalhe da pesquisa
1.
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.
Clin Infect Dis
; 78(3): 756-764, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340060
2.
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.
Antimicrob Agents Chemother
; 67(12): e0061123, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971239
3.
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children.
J Antimicrob Chemother
; 78(10): 2481-2488, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596982
4.
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children.
Clin Infect Dis
; 74(8): 1372-1381, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286843
5.
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
Clin Infect Dis
; 75(1): 141-151, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34665866
6.
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 66(6): e0226421, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35506699
7.
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial.
J Antimicrob Chemother
; 76(12): 3237-3246, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529779
8.
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133558
9.
Erratum for van der Laan et al., "Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis".
Antimicrob Agents Chemother
; 67(7): e0072023, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338349
10.
Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.
Sex Transm Infect
; 94(1): 55-61, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490581
11.
Emerging data on rifampicin pharmacokinetics and approaches to optimal dosing in children with tuberculosis.
Expert Rev Clin Pharmacol
; 15(2): 161-174, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285351
12.
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis.
Front Pharmacol
; 12: 722204, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34690765
13.
HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL.
Papillomavirus Res
; 3: 50-56, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28480334
14.
Probable Levofloxacin-associated Secondary Intracranial Hypertension in a Child With Multidrug-resistant Tuberculosis.
Pediatr Infect Dis J
; 35(6): 706-8, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26974890
15.
Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial.
J Infect
; 72(1): 60-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476151
16.
High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial.
J Acquir Immune Defic Syndr
; 68(2): 227-35, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25415290